intermittent fasting and glp 1 Danger! The truth about on a GLP-1 As a lifestyle medicine physician,

The insulin/insulin-like growth factor-1 (IGF-1) system has thereby emerged as a key regulator of cancer growth pathways

There have been postmarketing reports of acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis, in patients taking JANUVIA

Therefore, a better understanding of the mitochondrial metabolic programmes critical in supporting cancer cell survival following 5FU treatment is required to rationally design more effective fluoropyrimidine-based chemotherapy combination regimens

He calls BPC-157 "still the Wild West" because it lacks human RCTs, yet he prescribes GLP-1 agonists clinically and flagged the 39% lean mass loss problem from the STEP 1 trial before most physicians paid attention